Dopamine Agonists: all 968 studies that test it

Page 4 of 10. Open to participants first (53), then studies with results posted, then the rest; newest registration first within each.

• Oral Aripiprazole Open-Label Rollover StudyCompletedNCT01001702Phase 3Results posted
• Study of Droxidopa Treatment in Adults With Attention Deficit Hyperactivity Disorder With Co-administration of CarbidopaCompletedNCT00983814Phase 2Results posted
• A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).CompletedNCT00974974Phase 3Results posted
• Study in Healthy Volunteers to Prove That Two Rotigotine Patches From Different Manufacturing Sites Deliver Equivalent Drug Amount to the BodyCompletedNCT00957944Phase 1Results posted
• Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant DepressionCompletedNCT00953745Not applicableResults posted
• Trial of Aripiprazole in TrichotillomaniaCompletedNCT00947154Not applicableResults posted
• Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211)CompletedNCT00931944Phase 2Results posted
• Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute SchizophreniaCompletedNCT00905307Phase 2Results posted
• Examining the Effects of Antipsychotic Medications on Insulin SensitivityCompletedNCT00895921Phase 4Results posted
• Incomplete Response in Late Life Depression: Getting to Remission (IRL GREY)CompletedNCT00892047Phase 4Results posted
• Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive DisorderCompletedNCT00882362Phase 3Results posted
• Study in Healthy Volunteers to Prove That 2 Rotigotine Patches From Different Manufacturing Processes Deliver Equivalent Drug Amount to the Body.CompletedNCT00881894Phase 1Results posted
• A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's DiseaseCompletedNCT00880620Phase 3Results posted
• Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive DisorderCompletedNCT00876343Phase 3Results posted
• Study of Aripiprazole in the Treatment of Pervasive Developmental DisordersCompletedNCT00870727Phase 3Results posted
• A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-LevodopaCompletedNCT00869791Phase 2Results posted
• Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic SyndromeTerminatedNCT00857818Phase 3Results posted
• Acute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550)CompletedNCT00845000Phase 1Results posted
• The Relative Bioavailability Study of Two Ropinirole 0.25 mg Tablets Under Fed ConditionsCompletedNCT00830219Phase 1Results posted
• Ropinirole 0.25 mg Tablets Under Fasting ConditionsCompletedNCT00829504Phase 1Results posted
• Study on Tolerability of Levodopa/Carbidopa in Children With Angelman SyndromeCompletedNCT00829439Phase 1Results posted
• Comparison of Optimal Antipsychotic Treatments for Adults With SchizophreniaCompletedNCT00802100Phase 4Results posted
• Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive DisorderCompletedNCT00797966Phase 2Results posted
• Pilot Study to Evaluate Levodopa as Treatment for Residual AmblyopiaCompletedNCT00789672Phase 2Results posted
• Side Effect Study of Antipsychotic Medicines to Treat Childhood Bipolar DisorderTerminatedNCT00746252Not applicableResults posted
• Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaCompletedNCT00731549Phase 3Results posted
• Neurobiological Principles Applied to the Rehabilitation of Stroke PatientsCompletedNCT00715520Not applicableResults posted
• Carbidopa/Levodopa Combined With Behavioral Therapy for the Treatment of Cocaine DependenceCompletedNCT00713583Phase 2Results posted
• Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in SchizophreniaTerminatedNCT00712270Phase 4Results posted
• Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaCompletedNCT00706654Phase 3Results posted
• Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's DisorderCompletedNCT00706589Phase 3Results posted
• Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaCompletedNCT00705783Phase 3Results posted
• Pramipexole ER vs. Placebo in FibromyalgiaTerminatedNCT00689052Phase 2Results posted
• Peripheral Dopamine in Postural Tachycardia SyndromeCompletedNCT00685919Phase 2/3Results posted
• A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant TherapyCompletedNCT00683852Phase 3Results posted
• Open-label Extension Study of Pramipexole in the Treatment of Children and Adolescents With Tourette SyndromeTerminatedNCT00681863Phase 3Results posted
• An Exploratory Study of Naltrexone Plus Aripiprazole for Alcohol DependenceCompletedNCT00667875Phase 2Results posted
• A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) PatientsCompletedNCT00666965Phase 2Results posted
• Study of Aripiprazole to Reduce Medical Risks in Bipolar DisorderTerminatedNCT00665444Not applicableResults posted
• Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I DisorderCompletedNCT00665366Phase 3Results posted
• Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's DiseaseCompletedNCT00660673Phase 3Results posted
• Pramipexole in Out-patients With Idiopathic Restless Legs Syndrome (IRLS)CompletedNCT00654498Phase 3Results posted
• Safety and Tolerability Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00647296Phase 2Results posted
• Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing OffTerminatedNCT00642356Phase 4Results posted
• Phase 3 Study of MAP0004 in Adult MigraineursCompletedNCT00623636Phase 3Results posted
• Study of Aripiprazole to Treat Children and Adolescents With AutismCompletedNCT00619190Phase 2Results posted
• Aripiprazole Augmentation of SSRI Therapy in Treatment Refractory DepressionCompletedNCT00608543Phase 4Results posted
• A Multicenter, Investigative Study of the Safety and Efficacy of Extended Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed EpisodeCompletedNCT00606320Phase 3Results posted
• A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed EpisodeCompletedNCT00606281Phase 3Results posted
• A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed EpisodeCompletedNCT00606229Phase 3Results posted
• A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed EpisodeCompletedNCT00606177Phase 3Results posted
• Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).CompletedNCT00601523Phase 3Results posted
• An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's DiseaseCompletedNCT00599196Phase 3Results posted
• Cognitive Enhancement in Bipolar DisorderCompletedNCT00597896Phase 4Results posted
• A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing SurgeryCompletedNCT00594464Phase 4Results posted
• An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parkinson's DiseaseCompletedNCT00594386Phase 3Results posted
• An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.CompletedNCT00594165Phase 3Results posted
• Safety and Tolerability Trial of Switching From Ropinirole to RotigotineCompletedNCT00593606Phase 3Results posted
• Parcopa Versus Carbidopa-levodopa in a Single Dose Cross-over Comparison StudyCompletedNCT00590122Phase 4Results posted
• Long-term Safety Study of Open-label Pramipexole ER in Patients With Advanced PDCompletedNCT00577460Phase 3Results posted
• A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment PeriodCompletedNCT00560508Phase 2/3Results posted
• Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson DiseaseCompletedNCT00558025Phase 3Results posted
• The Combination of Aripiprazole and Antidepressants in Psychotic Major DepressionCompletedNCT00556140Phase 3Results posted
• Augmenting Effects of L-DOPS With Carbidopa and EntacaponeTerminatedNCT00547911Phase 1/2Results posted
• A Placebo-controlled Study for SPM 962 in Early Parkinson's Disease PatientsCompletedNCT00537485Phase 2/3Results posted
• Early Detection and Intervention for the Prevention of PsychosisCompletedNCT00531518Not applicableResults posted
• Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal PatchCompletedNCT00522379Phase 3Results posted
• Long-term Extension of RECOVER- Long-term Effect of the 24h Transdermal Delivery of Rotigotine in Subjects With Idiopathic Parkinson's DiseaseTerminatedNCT00519532Phase 3Results posted
• A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic SyndromeTerminatedNCT00508157Phase 4Results posted
• An Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Subjects With Idiopathic Parkinson's DiseaseCompletedNCT00505687Phase 3Results posted
• An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's DiseaseCompletedNCT00501969Phase 3Results posted
• Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS)CompletedNCT00498186Phase 2Results posted
• Aripiprazole Treatment for Methamphetamine Dependence Among High-risk IndividualsCompletedNCT00497055Phase 2Results posted
• Aripiprazole Augmentation of Antidepressants in PTSDCompletedNCT00489866Phase 2Results posted
• Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD PatientsCompletedNCT00479401Phase 3Results posted
• Randomized Evaluation of the 24-Hour Coverage: Efficacy of RotigotineCompletedNCT00474058Phase 3Results posted
• Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS)CompletedNCT00472199Phase 4Results posted
• Efficacy of Aripiprazole Versus Placebo in the Reduction of Aggressive and Aberrant Behavior in Autistic ChildrenCompletedNCT00468130Not applicableResults posted
• Metabolic Signatures and Biomarkers in SchizophreniaCompletedNCT00466310Phase 1Results posted
• Pivotal Study in Advanced Parkinsons Disease PatientsCompletedNCT00466167Phase 3Results posted
• The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults.CompletedNCT00464737Phase 2Results posted
• Efficacy and Safety of Cycloset® Compared With Placebo When Added to MetforminTerminatedNCT00441363Phase 3Results posted
• Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective DisorderCompletedNCT00423878Phase 4Results posted
• A Prospective Open-label Study of Aripiprazole in Fragile X SyndromeCompletedNCT00420459Phase 2Results posted
• A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) PatientsCompletedNCT00402233Phase 4Results posted
• Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism-CompletedNCT00392197Phase 4Results posted
• Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing-offCompletedNCT00391898Phase 4Results posted
• A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy and Safety in Patients With RLS.CompletedNCT00390689Phase 3Results posted
• Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS SymptomsCompletedNCT00389831Phase 2Results posted
• Safety and Tolerability Study of Cycloset in Treatment of Type 2 DiabetesCompletedNCT00377676Phase 3Results posted
• Effects of Aripiprazole on Cocaine Craving and Self-AdministrationCompletedNCT00373880Phase 2Results posted
• Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)CompletedNCT00365859Phase 3Results posted
• Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's SubjectsCompletedNCT00360568Phase 3Results posted
• The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs SyndromeCompletedNCT00357097Phase 3Results posted
• A Placebo-Controlled, Cross-Over Trial of AripiprazoleCompletedNCT00351936Phase 4Results posted
• Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With SchizophreniaCompletedNCT00345033Phase 4Results posted
• Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)CompletedNCT00337571Phase 3Results posted
• A Research Study Examining Migranal and Skin Sensitivity in Subjects With MigraineCompletedNCT00335777Phase 4Results posted
• Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's DiseaseCompletedNCT00335153Phase 3Results posted
• Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD).CompletedNCT00332241Phase 3Results posted

← Dopamine Agonists overview